LataMed AI is trading 7.79% down at $0.35, with no clear company-specific catalyst identified for September 14, 2026.
- The latest disclosed development was a September 9 cooperation agreement with Venezuelan science and health ministries for planned healthcare-technology deployment in La Guaira; it was not announced today.
- Healthcare stocks are broadly stronger, while major indexes are modestly lower, leaving the decline’s cause unclear.